Omada Health, Inc.
For the period ended Jun 30, 2026. Filed Aug 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 7, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations and Comprehensive Income Loss
(in thousands, except per-share data, unaudited)
| Three Months Ended June 30, · Six Months Ended June 30, | ||||||
|---|---|---|---|---|---|---|
| 2026 · 2025 · 2026 · 2025 | ||||||
| Revenue | ||||||
| Services (1) | $80,692 | $56,960 | $150,286 | $106,456 | ||
| Hardware (2) | 7,143 | 4,411 | 15,597 | 9,878 | ||
| Total revenue | 87,835 | 61,371 | 165,883 | 116,334 | ||
| Cost of revenue | ||||||
| Services (3) | 13,609 | 12,673 | 28,058 | 25,417 | ||
| Hardware | 10,439 | 8,392 | 25,345 | 18,711 | ||
| Total cost of revenue | 24,048 | 21,065 | 53,403 | 44,128 | ||
| Gross profit | 63,787 | 40,306 | 112,480 | 72,206 | ||
| Operating expenses | ||||||
| Research and development (4) | 14,625 | 10,024 | 27,322 | 18,830 | ||
| Sales and marketing (5) | 29,888 | 22,318 | 56,675 | 42,488 | ||
| General and administrative (6) | 15,725 | 12,308 | 29,715 | 23,628 | ||
| Total operating expenses | 60,238 | 44,650 | 113,712 | 84,946 | ||
| Operating income (loss) | 3,549 | (4,344) | (1,232) | (12,740) | ||
| Other income (expense), net | ||||||
| Interest expense | (14) | (1,094) | (32) | (2,168) | ||
| Interest income | 1,759 | 863 | 3,588 | 1,405 | ||
| Change in fair value of warrant liabilities | - | (736) | - | (1,256) | ||
| Total other income (expense), net | 1,745 | (967) | 3,556 | (2,019) | ||
| Income (loss) before provision for income taxes | 5,294 | (5,311) | 2,324 | (14,759) | ||
| Provision for income taxes | - | - | - | - | ||
| Net income (loss) and comprehensive income (loss) | $5,294 | $(5,311) | $2,324 | $(14,759) | ||
| Net income (loss) per share | ||||||
| Basic | $0.09 | $(0.24) | $0.04 | $(0.98) | ||
| Diluted | $0.08 | $(0.24) | $0.04 | $(0.98) | ||
| Weighted-average shares outstanding | ||||||
| Basic | 59,685 | 21,971 | 59,306 | 15,107 | ||
| Diluted | 63,947 | 21,971 | 64,345 | 15,107 | ||
(1)Includes amounts from a related party of $51.4 million and $36.5 million for the three months ended June 30, 2026 and 2025, respectively, and $97.4 million and $66.4 million for the six months ended June 30, 2026 and 2025, respectively.
(2)Includes amounts from a related party of $4.8 million and $2.6 million for the three months ended June 30, 2026 and 2025, respectively, and $9.9 million and $6.0 million for the six months ended June 30, 2026 and 2025, respectively.
(3)Includes amounts from a related party of $1.4 million and $1.2 million for the three months ended June 30, 2026 and 2025, respectively, and $2.7 million and $2.4 million for the six months ended June 30, 2026 and 2025, respectively.
(4)Includes amounts from a related party of $0.8 million and $0.5 million for the three months ended June 30, 2026 and 2025, respectively, and $1.5 million and $1.0 million for the six months ended June 30, 2026 and 2025, respectively.
(5)Includes amounts from a related party of $8.5 million and $6.6 million for the three months ended June 30, 2026 and 2025, respectively, and $16.9 million and $12.2 million for the six months ended June 30, 2026 and 2025, respectively.
(6)Includes amounts from a related party of $0.5 million and $0.4 million for the three months ended June 30, 2026 and 2025, respectively, and $1.0 million and $0.7 million for the six months ended June 30, 2026 and 2025, respectively.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.